Vontobel Holding’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Hold |
3,800
| – | – | ﹤0.01% | 903 |
|
|
2025
Q1 | $346K | Hold |
3,800
| – | – | ﹤0.01% | 882 |
|
|
2024
Q4 | $328K | Hold |
3,800
| – | – | ﹤0.01% | 902 |
|
|
2024
Q3 | $361K | Sell |
3,800
-3,000
| -44% | -$285K | ﹤0.01% | 872 |
|
|
2024
Q2 | $622K | Buy |
6,800
+2,800
| +70% | +$256K | ﹤0.01% | 709 |
|
|
2024
Q1 | $363K | Hold |
4,000
| – | – | ﹤0.01% | 856 |
|
|
2023
Q4 | $325K | Sell |
4,000
-1,000
| -20% | -$81.4K | ﹤0.01% | 906 |
|
|
2023
Q3 | $399K | Sell |
5,000
-18,000
| -78% | -$1.44M | ﹤0.01% | 826 |
|
|
2023
Q2 | $1.81M | Buy |
23,000
+2,500
| +12% | +$197K | 0.02% | 461 |
|
|
2023
Q1 | $1.59M | Sell |
20,500
-2,500
| -11% | -$194K | 0.01% | 472 |
|
|
2022
Q4 | $1.79M | Buy |
23,000
+3,000
| +15% | +$233K | 0.02% | 437 |
|
|
2022
Q3 | $1.35M | Buy |
20,000
+2,500
| +14% | +$168K | 0.02% | 481 |
|
|
2022
Q2 | $1.35M | Hold |
17,500
| – | – | 0.01% | 477 |
|
|
2022
Q1 | $1.4M | Buy |
17,500
+6,250
| +56% | +$499K | 0.01% | 524 |
|
|
2021
Q4 | $866K | Buy |
11,250
+1,250
| +13% | +$96.2K | 0.01% | 671 |
|
|
2021
Q3 | $728K | Buy |
10,000
+3,500
| +54% | +$255K | 0.01% | 687 |
|
|
2021
Q2 | $475K | Buy |
6,500
+1,500
| +30% | +$110K | ﹤0.01% | 777 |
|
|
2021
Q1 | $345K | Buy |
+5,000
| New | +$345K | ﹤0.01% | 757 |
|